FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE

FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE was reported 43081 times

FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ANTACID THERAPY 64 0.4923
1 SLEEP DISORDER THERAPY 75 0.3788
2 APPENDICOLITH 138 0.3566
3 PULMONARY VASCULITIS 155 0.2881
4 ANALGESIC THERAPY 91 0.2835
5 TOTAL LUNG CAPACITY ABNORMAL 104 0.2674
6 DRUG THERAPY 89 0.2625
7 PRODUCT CONFUSION 200 0.2519
8 CAPILLARITIS 68 0.2464
9 ANTICOAGULANT THERAPY 64 0.2254
10 SPIROMETRY ABNORMAL 108 0.1806
11 MITE ALLERGY 111 0.1695
12 BACTEROIDES INFECTION 39 0.1494
13 MALIGNANT MELANOMA STAGE 0 31 0.1483
14 CONGENITAL HIATUS HERNIA 33 0.1447
15 ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE 99 0.1351
16 MYCOTIC ALLERGY 115 0.1345
17 DUST ALLERGY 119 0.1213
18 PRODUCT COMPLAINT 3063 0.1208
19 NEURITIS 157 0.1016
20 CONJUNCTIVITIS ALLERGIC 111 0.0749
21 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 3401 0.0727
22 RESPIRATORY SYMPTOM 202 0.0710
23 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 137 0.0671
24 BREAST CONSERVING SURGERY 31 0.0605
25 DEVICE USE CONFUSION 31 0.0593
26 WRONG STRENGTH 18 0.0545
27 ASBESTOSIS 13 0.0459
28 BLOOD PHOSPHORUS INCREASED 125 0.0457
29 TOTAL LUNG CAPACITY DECREASED 70 0.0438
30 HYPERPHOSPHATAEMIA 88 0.0409
31 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 37 0.0399
32 INCREASED BRONCHIAL SECRETION 100 0.0391
33 NORMOCHROMIC NORMOCYTIC ANAEMIA 110 0.0366
34 FORCED EXPIRATORY VOLUME DECREASED 103 0.0363
35 PRODUCT LABEL CONFUSION 210 0.0360
36 OXYGEN THERAPY 59 0.0359
37 LABELLED DRUG-DRUG INTERACTION ISSUE 50 0.0345
38 PRODUCT SELECTION ERROR 37 0.0337
39 COATING IN MOUTH 18 0.0337
40 PRODUCT DISPENSING ERROR 725 0.0333
41 DEVICE DISPENSING ERROR 39 0.0330
42 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1648 0.0316
43 PRODUCT PACKAGING CONFUSION 74 0.0305
44 INCREASED VISCOSITY OF BRONCHIAL SECRETION 19 0.0298
45 PULMONARY ALVEOLAR HAEMORRHAGE 157 0.0280
46 CANDIDA INFECTION 470 0.0278
47 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS PERFORMED IN ERROR 17 0.0276
48 OROPHARYNGEAL CANDIDIASIS 25 0.0276
49 NEUROLOGICAL SYMPTOM 156 0.0273
50 SUPERFICIAL VEIN THROMBOSIS 22 0.0261
51 SPUTUM INCREASED 56 0.0259
52 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 439 0.0258
53 LABELLED DRUG-DISEASE INTERACTION MEDICATION ERROR 15 0.0257
54 INCREASED VISCOSITY OF UPPER RESPIRATORY SECRETION 19 0.0249
55 RESPIRATORY TRACT IRRITATION 24 0.0230
56 OXYGEN SATURATION ABNORMAL 65 0.0229
57 OBSTRUCTIVE AIRWAYS DISORDER 252 0.0226
58 FULL BLOOD COUNT ABNORMAL 239 0.0226
59 AORTIC STENOSIS 77 0.0221
60 LUNG OPERATION 18 0.0215
61 PULMONARY PAIN 62 0.0212
62 INFUSION SITE DISCHARGE 36 0.0205
63 DYSPHONIA 1190 0.0203
64 PRODUCTIVE COUGH 946 0.0198
65 DEVICE DEPOSIT ISSUE 40 0.0196
66 CORONAVIRUS TEST POSITIVE 20 0.0194
67 LUNG OPACITY 51 0.0193
68 SPUTUM RETENTION 19 0.0192
69 ARTERIOSCLEROSIS CORONARY ARTERY 124 0.0187
70 TONGUE ERYTHEMA 15 0.0182
71 BLOOD URIC ACID INCREASED 105 0.0182
72 TONGUE COATED 31 0.0180
73 ORAL CANDIDIASIS 233 0.0177
74 OXYGEN CONSUMPTION INCREASED 42 0.0176
75 IRON DEFICIENCY 78 0.0173
76 SECRETION DISCHARGE 216 0.0172
77 PRODUCT AFTER TASTE 16 0.0168
78 ASTHMA 1886 0.0167
79 WHEEZING 989 0.0167
80 INTERCEPTED PRODUCT PRESCRIBING ERROR 22 0.0166
81 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 84 0.0166
82 INFUSION SITE MASS 18 0.0166
83 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 145 0.0164
84 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 101 0.0163
85 HOSPICE CARE 160 0.0162
86 PATIENT DISSATISFACTION WITH TREATMENT 31 0.0161
87 SPUTUM DISCOLOURED 150 0.0158
88 VASCULITIS 180 0.0154
89 APPENDICITIS 144 0.0154
90 INFUSION SITE BRUISING 33 0.0153
91 EXTRA DOSE ADMINISTERED 615 0.0152
92 OBSTRUCTIVE SLEEP APNOEA SYNDROME 22 0.0151
93 FOREIGN BODY IN THROAT 47 0.0149
94 CHRONIC RESPIRATORY FAILURE 18 0.0149
95 CARBON DIOXIDE INCREASED 20 0.0147
96 EMPHYSEMA 145 0.0144
97 APHONIA 197 0.0141
98 OBSTRUCTION 56 0.0140
99 SEASONAL ALLERGY 198 0.0140
100 INTERCEPTED PRODUCT DISPENSING ERROR 23 0.0139
101 MYASTHENIA GRAVIS 111 0.0137
102 INFUSION SITE HAEMORRHAGE 45 0.0137
103 DYSPNOEA EXERTIONAL 512 0.0136
104 BRONCHIECTASIS 91 0.0135
105 PULMONARY FUNCTION TEST ABNORMAL 21 0.0135
106 BREATH SOUNDS ABNORMAL 66 0.0134
107 NOCTURNAL DYSPNOEA 17 0.0133
108 INABILITY TO AFFORD MEDICATION 132 0.0133
109 PULMONARY CONGESTION 175 0.0133
110 PULMONARY FIBROSIS 254 0.0132
111 MULTIPLE ALLERGIES 103 0.0131
112 PNEUMONIA PSEUDOMONAL 20 0.0130
113 DEVICE INFUSION ISSUE 32 0.0129
114 ARTERIOSCLEROSIS 120 0.0127
115 DEVICE USE ERROR 442 0.0127
116 IMPAIRED QUALITY OF LIFE 181 0.0126
117 HYPOPHOSPHATAEMIA 93 0.0126
118 PRODUCT DOSE OMISSION ISSUE 3485 0.0118
119 PNEUMONIA INFLUENZAL 14 0.0118
120 THROAT CLEARING 44 0.0117
121 URINE FLOW DECREASED 28 0.0117
122 VENTRICULAR FIBRILLATION 129 0.0116
123 PLEURITIC PAIN 32 0.0116
124 INFUSION SITE WARMTH 14 0.0114
125 POST-ACUTE COVID-19 SYNDROME 14 0.0113
126 SUFFOCATION FEELING 28 0.0113
127 INFUSION SITE PRURITUS 35 0.0111
128 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 532 0.0111
129 OROPHARYNGEAL DISCOMFORT 100 0.0111
130 HAEMOPTYSIS 308 0.0110
131 RESPIRATION ABNORMAL 76 0.0110
132 PULMONARY FUNCTION TEST DECREASED 48 0.0110
133 INFUSION SITE IRRITATION 14 0.0109
134 RHONCHI 15 0.0109
135 MYCOBACTERIUM AVIUM COMPLEX INFECTION 29 0.0108
136 CARDIOGENIC SHOCK 155 0.0108
137 COUGH 3012 0.0107
138 DYSPNOEA 6025 0.0106
139 RESPIRATORY TRACT CONGESTION 169 0.0106
140 LUNG DISORDER 517 0.0105
141 INFUSION SITE SWELLING 66 0.0105
142 OXYGEN SATURATION DECREASED 572 0.0102
143 VOCAL CORD DISORDER 20 0.0101
144 CONTRAINDICATED PRODUCT PRESCRIBED 17 0.0101
145 UPPER-AIRWAY COUGH SYNDROME 81 0.0098
146 DRY THROAT 98 0.0096
147 CHOKING SENSATION 53 0.0096
148 PULMONARY MASS 143 0.0096
149 CHOKING 187 0.0096
150 INFUSION SITE RASH 13 0.0095
151 INFUSION SITE INDURATION 14 0.0094
152 INTENTIONAL UNDERDOSE 69 0.0094
153 NODULE 123 0.0094
154 NEAR DEATH EXPERIENCE 31 0.0094
155 TROPONIN INCREASED 71 0.0093
156 INFUSION SITE ERYTHEMA 78 0.0092
157 ORAL FUNGAL INFECTION 25 0.0091
158 ORAL MUCOSAL ERUPTION 14 0.0091
159 PRODUCT PRESCRIBING ERROR 217 0.0091
160 BENIGN PROSTATIC HYPERPLASIA 45 0.0087
161 BLOOD CALCIUM INCREASED 76 0.0087
162 TONGUE DISCOMFORT 36 0.0085
163 PARANASAL SINUS DISCOMFORT 32 0.0084
164 THROAT IRRITATION 373 0.0083
165 OESOPHAGEAL CANDIDIASIS 33 0.0083
166 LOWER RESPIRATORY TRACT CONGESTION 14 0.0082
167 INFUSION SITE PAIN 106 0.0082
168 ESSENTIAL HYPERTENSION 15 0.0082
169 BRONCHITIS CHRONIC 20 0.0082
170 DRUG TOLERANCE DECREASED 23 0.0082
171 LUNG NEOPLASM MALIGNANT 336 0.0082
172 DRUG EFFECT LESS THAN EXPECTED 121 0.0082
173 INTENTIONAL DOSE OMISSION 232 0.0081
174 RALES 47 0.0081
175 TONGUE BLISTERING 18 0.0081
176 BACTERIAL INFECTION 149 0.0080
177 PRODUCT DOSE OMISSION IN ERROR 225 0.0079
178 HYPERVOLAEMIA 39 0.0079
179 HYPERLIPIDAEMIA 94 0.0079
180 CORONAVIRUS INFECTION 52 0.0079
181 INSURANCE ISSUE 120 0.0078
182 VOCAL CORD PARALYSIS 14 0.0078
183 PRODUCT STORAGE ISSUE 29 0.0076
184 SUSPECTED COVID-19 25 0.0076
185 SINUS DISORDER 150 0.0076
186 PHARYNGEAL SWELLING 74 0.0076
187 CARDIAC PACEMAKER INSERTION 45 0.0075
188 RESPIRATORY TRACT INFECTION 195 0.0075
189 PAINFUL RESPIRATION 18 0.0075
190 CARDIAC OPERATION 64 0.0074
191 RHINITIS ALLERGIC 33 0.0074
192 HYPOXIA 261 0.0074
193 PNEUMONIA BACTERIAL 68 0.0074
194 HAEMATOLOGICAL INFECTION 18 0.0074
195 LIP PAIN 21 0.0073
196 MIDDLE EAR EFFUSION 16 0.0072
197 PRODUCT RESIDUE PRESENT 39 0.0072
198 REHABILITATION THERAPY 28 0.0072
199 INTERCEPTED MEDICATION ERROR 33 0.0071
200 PRODUCT PRESCRIBING ISSUE 155 0.0071
201 EXPOSURE VIA SKIN CONTACT 183 0.0071
202 URINARY RETENTION 233 0.0070
203 GOUT 124 0.0069
204 CHEST DISCOMFORT 707 0.0069
205 TASTE DISORDER 140 0.0069
206 ASTHMATIC CRISIS 25 0.0068
207 PNEUMONIA 2203 0.0068
208 ILLNESS 698 0.0068
209 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 116 0.0068
210 HOSPITALISATION 1036 0.0067
211 ATYPICAL PNEUMONIA 20 0.0067
212 JOINT NOISE 13 0.0066
213 RESPIRATORY SYNCYTIAL VIRUS INFECTION 57 0.0065
214 OROPHARYNGEAL PAIN 591 0.0064
215 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 451 0.0063
216 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO DEVICE USE ERROR 15 0.0063
217 DYSPNOEA AT REST 18 0.0062
218 TONGUE DISCOLOURATION 27 0.0062
219 HERNIA REPAIR 16 0.0062
220 ASPIRATION 67 0.0061
221 ORAL DISCOMFORT 85 0.0061
222 PNEUMONIA FUNGAL 24 0.0061
223 DEVICE DELIVERY SYSTEM ISSUE 166 0.0061
224 MICTURITION DISORDER 21 0.0061
225 PARANASAL SINUS HYPERSECRETION 23 0.0060
226 RHINORRHOEA 389 0.0060
227 SINUS PAIN 14 0.0060
228 ULCER 95 0.0060
229 BRONCHITIS 440 0.0059
230 GLOSSITIS 21 0.0059
231 EYELID MARGIN CRUSTING 17 0.0059
232 CHRONIC SINUSITIS 22 0.0059
233 NASAL DRYNESS 36 0.0057
234 LOWER RESPIRATORY TRACT INFECTION 261 0.0057
235 HEART RATE ABNORMAL 32 0.0057
236 PRODUCT USE IN UNAPPROVED INDICATION 1422 0.0057
237 BLOOD TEST ABNORMAL 80 0.0057
238 MIDDLE INSOMNIA 106 0.0057
239 INCREASED UPPER AIRWAY SECRETION 29 0.0056
240 NECK SURGERY 13 0.0056
241 RETCHING 118 0.0055
242 SENSITIVITY TO WEATHER CHANGE 29 0.0055
243 HAEMOGLOBIN INCREASED 25 0.0055
244 RHINALGIA 15 0.0055
245 COLONOSCOPY 12 0.0054
246 OCULAR DISCOMFORT 61 0.0054
247 UPPER RESPIRATORY TRACT INFECTION 251 0.0054
248 CATARACT OPERATION 32 0.0054
249 PRODUCT DOSE OMISSION 349 0.0053
250 LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE IV 18 0.0053
251 PRODUCT COMMUNICATION ISSUE 47 0.0053
252 HYPERCAPNIA 16 0.0053
253 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 955 0.0053
254 NASAL CONGESTION 311 0.0053
255 SKIN ABRASION 25 0.0053
256 MICTURITION URGENCY 60 0.0052
257 ASCITES 154 0.0052
258 MULTIPLE ORGAN DYSFUNCTION SYNDROME 148 0.0052
259 NEURALGIA 127 0.0052
260 EYELID IRRITATION 13 0.0052
261 END STAGE RENAL DISEASE 94 0.0051
262 RHINOVIRUS INFECTION 20 0.0051
263 DEVICE POWER SOURCE ISSUE 15 0.0051
264 ORAL PAIN 115 0.0051
265 LACTOSE INTOLERANCE 13 0.0051
266 HYPOTHYROIDISM 162 0.0051
267 DRUG DISPENSING ERROR 77 0.0050
268 SINUS CONGESTION 68 0.0050
269 SKIN LACERATION 54 0.0050
270 DRY MOUTH 402 0.0049
271 EMERGENCY CARE 15 0.0049
272 DYSURIA 182 0.0049
273 COVID-19 PNEUMONIA 58 0.0049
274 PRODUCT ADMINISTRATION INTERRUPTED 38 0.0048
275 SNEEZING 108 0.0048
276 RESPIRATORY DISORDER 144 0.0048
277 LIP BLISTER 13 0.0048
278 NECK INJURY 14 0.0048
279 SNORING 18 0.0048
280 PNEUMOTHORAX 75 0.0047
281 PNEUMONIA VIRAL 15 0.0047
282 ANEURYSM 23 0.0046
283 RIB FRACTURE 95 0.0046
284 COVID-19 806 0.0046
285 SINUSITIS 466 0.0045
286 EXPIRED DEVICE USED 15 0.0045
287 SYMPTOM RECURRENCE 27 0.0045
288 UPPER RESPIRATORY TRACT CONGESTION 13 0.0045
289 IMPAIRED GASTRIC EMPTYING 61 0.0045
290 INCORRECT DRUG ADMINISTRATION RATE 19 0.0045
291 SLEEP DISORDER 310 0.0044
292 HORDEOLUM 19 0.0044
293 INITIAL INSOMNIA 45 0.0044
294 SPINAL OPERATION 54 0.0044
295 CHAPPED LIPS 19 0.0044
296 STENT PLACEMENT 35 0.0043
297 EYE OPERATION 20 0.0043
298 THROMBOSIS 349 0.0043
299 AGEUSIA 108 0.0043
300 INCORRECT DOSE ADMINISTERED 988 0.0043
301 HYPOPNOEA 15 0.0043
302 EXPIRED PRODUCT ADMINISTERED 142 0.0043
303 MACULAR DEGENERATION 49 0.0041
304 FOREIGN BODY SENSATION IN EYES 26 0.0041
305 BRONCHOSPASM 58 0.0041
306 NASAL POLYPS 20 0.0041
307 CATHETERISATION CARDIAC 18 0.0041
308 CERVICAL VERTEBRAL FRACTURE 14 0.0041
309 PRESCRIBED OVERDOSE 78 0.0040
310 HIP FRACTURE 129 0.0040
311 ACUTE RESPIRATORY FAILURE 77 0.0040
312 EXERCISE TOLERANCE DECREASED 23 0.0040
313 GLAUCOMA 76 0.0039
314 CORONARY ARTERIAL STENT INSERTION 20 0.0039
315 GASTRIC INFECTION 15 0.0039
316 RHINITIS 31 0.0038
317 INFLUENZA 428 0.0038
318 CONDITION AGGRAVATED 1152 0.0038
319 HIP ARTHROPLASTY 58 0.0038
320 URINARY TRACT DISORDER 17 0.0038
321 DERMATITIS CONTACT 43 0.0038
322 PULMONARY THROMBOSIS 41 0.0038
323 JOINT INJURY 80 0.0037
324 PRODUCT DISPENSING ISSUE 16 0.0037
325 DECREASED INTEREST 22 0.0037
326 BLOOD PRESSURE ABNORMAL 74 0.0037
327 PERIORBITAL SWELLING 21 0.0037
328 CARDIAC FLUTTER 24 0.0037
329 THERAPEUTIC RESPONSE SHORTENED 123 0.0037
330 CHEMOTHERAPY 14 0.0037
331 INFUSION SITE EXTRAVASATION 23 0.0037
332 POLLAKIURIA 153 0.0037
333 SWELLING OF EYELID 23 0.0037
334 LIMB INJURY 99 0.0036
335 PRODUCT STORAGE ERROR 319 0.0036
336 MOUTH SWELLING 21 0.0036
337 EYE PRURITUS 122 0.0036
338 DRY EYE 181 0.0036
339 EOSINOPHIL COUNT INCREASED 30 0.0036
340 IRON DEFICIENCY ANAEMIA 33 0.0036
341 ORAL DISORDER 26 0.0035
342 HYPONATRAEMIA 198 0.0035
343 HIP SURGERY 19 0.0035
344 BRAIN FOG 55 0.0035
345 SPINAL FRACTURE 70 0.0035
346 EYE PAIN 196 0.0035
347 MUSCLE STRAIN 30 0.0035
348 FEELING JITTERY 66 0.0035
349 DECREASED ACTIVITY 37 0.0034
350 ANKLE FRACTURE 53 0.0034
351 AORTIC ANEURYSM 26 0.0034
352 HEART RATE INCREASED 338 0.0034
353 SPINAL STENOSIS 14 0.0034
354 GLUCOSE TOLERANCE IMPAIRED 20 0.0034
355 PRODUCT DISTRIBUTION ISSUE 31 0.0033
356 VIRAL INFECTION 111 0.0033
357 SKIN ATROPHY 19 0.0033
358 DIZZINESS POSTURAL 32 0.0033
359 ATRIAL FIBRILLATION 320 0.0033
360 DISEASE COMPLICATION 15 0.0033
361 SHOULDER OPERATION 14 0.0033
362 PSEUDOMONAS INFECTION 28 0.0033
363 PRODUCT USE ISSUE 611 0.0032
364 SLEEP APNOEA SYNDROME 62 0.0032
365 DIVERTICULITIS 90 0.0032
366 FOOT OPERATION 16 0.0032
367 MUSCULOSKELETAL CHEST PAIN 50 0.0032
368 ROSACEA 15 0.0032
369 THERAPY INTERRUPTED 230 0.0032
370 PULMONARY HYPERTENSION 67 0.0032
371 DIVERTICULUM INTESTINAL 14 0.0032
372 UNDERDOSE 233 0.0032
373 POOR VENOUS ACCESS 33 0.0032
374 WALKING AID USER 21 0.0032
375 PRODUCT TASTE ABNORMAL 43 0.0032
376 BLOOD CHOLESTEROL INCREASED 148 0.0032
377 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 107 0.0032
378 SARCOIDOSIS 15 0.0032
379 LIMB OPERATION 15 0.0031
380 THERAPEUTIC RESPONSE UNEXPECTED 140 0.0031
381 PSYCHIATRIC SYMPTOM 23 0.0031
382 FLUID RETENTION 158 0.0031
383 DEVICE USE ISSUE 54 0.0031
384 WRIST FRACTURE 37 0.0031
385 PULMONARY OEDEMA 138 0.0031
386 BLOOD SODIUM DECREASED 58 0.0031
387 THROAT CANCER 13 0.0031
388 POST PROCEDURAL INFECTION 25 0.0031
389 DIABETES MELLITUS 234 0.0031
390 NASOPHARYNGITIS 563 0.0031
391 INTENTIONAL PRODUCT MISUSE 267 0.0030
392 KNEE OPERATION 30 0.0030
393 TOOTHACHE 55 0.0030
394 GAIT INABILITY 101 0.0030
395 ARTHRITIS INFECTIVE 14 0.0030
396 EAR INFECTION 80 0.0030
397 HYPERCHOLESTEROLAEMIA 29 0.0030
398 SKIN SWELLING 26 0.0030
399 THERAPY NON-RESPONDER 134 0.0030
400 INJECTION SITE DISCHARGE 16 0.0030
401 ABDOMINAL DISTENSION 310 0.0030
402 ARTHROPOD BITE 22 0.0030
403 LOWER LIMB FRACTURE 57 0.0030
404 BACK PAIN 688 0.0030
405 CORONARY ARTERY BYPASS 17 0.0030
406 SARS-COV-2 TEST POSITIVE 39 0.0030
407 FUNGAL INFECTION 98 0.0029
408 SCRATCH 31 0.0029
409 EAR PAIN 57 0.0029
410 RESPIRATORY RATE INCREASED 26 0.0029
411 LACRIMATION INCREASED 88 0.0029
412 BRAIN NEOPLASM MALIGNANT 13 0.0029
413 PHARYNGITIS 36 0.0029
414 VISION BLURRED 398 0.0029
415 LUNG INFECTION 45 0.0029
416 EYE DISORDER 95 0.0029
417 PERIPHERAL SWELLING 445 0.0029
418 ENERGY INCREASED 17 0.0029
419 EPISTAXIS 214 0.0029
420 PRODUCT USE COMPLAINT 45 0.0029
421 PULMONARY EMBOLISM 271 0.0028
422 THERAPEUTIC PRODUCT EFFECT DELAYED 13 0.0028
423 KNEE ARTHROPLASTY 60 0.0028
424 SURGERY 167 0.0028
425 THERAPY CHANGE 28 0.0028
426 CONCUSSION 22 0.0028
427 QUALITY OF LIFE DECREASED 38 0.0028
428 EAR DISCOMFORT 29 0.0028
429 SEPSIS 315 0.0028
430 NERVOUSNESS 147 0.0028
431 ARTERIAL OCCLUSIVE DISEASE 22 0.0028
432 CHEST PAIN 518 0.0028
433 GASTROINTESTINAL INFECTION 25 0.0028
434 DRUG INEFFECTIVE 3674 0.0028
435 DEATH 2401 0.0028
436 PANIC REACTION 20 0.0028
437 CATARACT 165 0.0028
438 BACK DISORDER 45 0.0028
439 GINGIVAL PAIN 22 0.0028
440 BONE CANCER 12 0.0028
441 BACK INJURY 30 0.0028
442 POLYP 18 0.0027
443 HEAD INJURY 87 0.0027
444 BLOOD DISORDER 22 0.0027
445 DRUG DOSE OMISSION BY DEVICE 215 0.0027
446 HERNIA 53 0.0027
447 CARDIAC DISORDER 256 0.0027
448 NEOPLASM MALIGNANT 182 0.0027
449 GLOSSODYNIA 61 0.0027
450 DEMENTIA 76 0.0027
451 NOCTURIA 33 0.0027
452 SENSITIVE SKIN 20 0.0027
453 CARDIAC FAILURE CONGESTIVE 217 0.0027
454 SINUS HEADACHE 16 0.0027
455 WEIGHT FLUCTUATION 28 0.0027
456 PRODUCT LEAKAGE 15 0.0027
457 WRONG PRODUCT ADMINISTERED 18 0.0027
458 ORAL HERPES 52 0.0027
459 UPPER LIMB FRACTURE 53 0.0027
460 ROTATOR CUFF SYNDROME 34 0.0026
461 LIGAMENT SPRAIN 26 0.0026
462 SWOLLEN TONGUE 82 0.0026
463 MUSCULOSKELETAL DISCOMFORT 45 0.0026
464 FOOD POISONING 14 0.0026
465 SENSATION OF FOREIGN BODY 22 0.0026
466 INTERCEPTED PRODUCT ADMINISTRATION ERROR 20 0.0026
467 GINGIVITIS 14 0.0026
468 PRODUCT PREPARATION ISSUE 17 0.0026
469 URINARY TRACT INFECTION 442 0.0026
470 ASPERGILLUS INFECTION 17 0.0026
471 FALL 859 0.0026
472 PRODUCT PREPARATION ERROR 53 0.0026
473 BLOOD PRESSURE DECREASED 171 0.0026
474 SCIATICA 41 0.0026
475 CEREBRAL DISORDER 19 0.0026
476 POOR QUALITY PRODUCT ADMINISTERED 27 0.0026
477 LIVER FUNCTION TEST INCREASED 55 0.0026
478 THROAT TIGHTNESS 69 0.0025
479 GASTROENTERITIS VIRAL 46 0.0025
480 SKIN MASS 17 0.0025
481 CYSTITIS 81 0.0025
482 PROSTATIC DISORDER 14 0.0025
483 FOOT FRACTURE 48 0.0025
484 TREATMENT NONCOMPLIANCE 138 0.0025
485 ULCER HAEMORRHAGE 17 0.0025
486 CONSTIPATION 541 0.0025
487 DEVICE PHYSICAL PROPERTY ISSUE 19 0.0025
488 EYE INFECTION 28 0.0025
489 THERAPY CESSATION 127 0.0025
490 HIATUS HERNIA 32 0.0025
491 ATRIOVENTRICULAR BLOCK 19 0.0025
492 SWELLING 230 0.0025
493 EOSINOPHILIA 43 0.0025
494 ILL-DEFINED DISORDER 149 0.0025
495 GASTROOESOPHAGEAL REFLUX DISEASE 197 0.0024
496 VITREOUS FLOATERS 24 0.0024
497 PELVIC FRACTURE 19 0.0024
498 HYPOGAMMAGLOBULINAEMIA 16 0.0024
499 DRUG INTOLERANCE 235 0.0024
500 ANOSMIA 35 0.0024
501 PLEURAL EFFUSION 147 0.0024
502 PANIC ATTACK 88 0.0024
503 OSTEOPOROSIS 99 0.0024
504 EYE DISCHARGE 25 0.0024
505 INCORRECT DOSE ADMINISTERED BY DEVICE 63 0.0024
506 CHEILITIS 13 0.0024
507 URINE OUTPUT DECREASED 21 0.0024
508 NASAL DISCOMFORT 19 0.0024
509 HEART RATE IRREGULAR 54 0.0024
510 URINE ODOUR ABNORMAL 14 0.0024
511 CORONARY ARTERY DISEASE 72 0.0024
512 INCONTINENCE 25 0.0024
513 FACIAL PAIN 21 0.0024
514 TONGUE DISORDER 17 0.0023
515 BLOOD PRESSURE INCREASED 359 0.0023
516 FAECES SOFT 17 0.0023
517 ANAL INCONTINENCE 21 0.0023
518 FOOD ALLERGY 18 0.0023
519 POOR QUALITY SLEEP 50 0.0023
520 PHARYNGITIS STREPTOCOCCAL 25 0.0023
521 INCREASED TENDENCY TO BRUISE 21 0.0023
522 PALPITATIONS 267 0.0023
523 ATELECTASIS 22 0.0023
524 HYPERTENSION 482 0.0023
525 MENTAL IMPAIRMENT 55 0.0023
526 FEEDING DISORDER 46 0.0023
527 HEADACHE 1420 0.0023
528 TOOTH ABSCESS 23 0.0023
529 RESTLESS LEGS SYNDROME 41 0.0023
530 NECK PAIN 126 0.0023
531 PAROSMIA 17 0.0023
532 HYPERVENTILATION 13 0.0022
533 FEAR OF INJECTION 16 0.0022
534 HYPERSOMNIA 64 0.0022
535 SKIN INFECTION 25 0.0022
536 HYPOACUSIS 95 0.0022
537 TREMOR 364 0.0022
538 PLEURISY 13 0.0022
539 HYPOAESTHESIA ORAL 33 0.0022
540 CHOLECYSTECTOMY 25 0.0022
541 DISABILITY 43 0.0022
542 BODY HEIGHT DECREASED 23 0.0021
543 HEAD DISCOMFORT 38 0.0021
544 ASTHENIA 806 0.0021
545 EYE IRRITATION 123 0.0021
546 LIP SWELLING 71 0.0021
547 HAND FRACTURE 15 0.0021
548 PAIN IN EXTREMITY 623 0.0021
549 ACCIDENTAL EXPOSURE TO PRODUCT 216 0.0021
550 ACCIDENT 25 0.0021
551 ARTHRALGIA 870 0.0021
552 RASH MACULAR 73 0.0021
553 STOMATITIS 126 0.0021
554 LOCALISED INFECTION 50 0.0021
555 VISUAL IMPAIRMENT 256 0.0021
556 URINARY INCONTINENCE 61 0.0021
557 NERVE COMPRESSION 19 0.0021
558 IMMUNE SYSTEM DISORDER 27 0.0020
559 DIZZINESS 1020 0.0020
560 DYSGEUSIA 151 0.0020
561 PRODUCT ADMINISTRATION ERROR 41 0.0020
562 MALAISE 888 0.0020
563 LYMPHOEDEMA 14 0.0020
564 GENERAL PHYSICAL HEALTH DETERIORATION 234 0.0020
565 OVERDOSE 436 0.0020
566 PNEUMONITIS 55 0.0020
567 ANXIETY 574 0.0020
568 INFECTION 290 0.0020
569 RESPIRATORY FAILURE 146 0.0020
570 SKIN FISSURES 39 0.0020
571 CONTUSION 192 0.0020
572 RASH PRURITIC 108 0.0020
573 ARTHRITIS 156 0.0020
574 FRUSTRATION TOLERANCE DECREASED 16 0.0020
575 POST PROCEDURAL COMPLICATION 38 0.0020
576 SKIN EXFOLIATION 166 0.0020
577 THERAPEUTIC PRODUCT EFFECT DECREASED 88 0.0020
578 MUSCLE SPASMS 360 0.0020
579 GAIT DISTURBANCE 375 0.0020
580 SKIN HAEMORRHAGE 29 0.0020
581 INTRAOCULAR PRESSURE INCREASED 25 0.0020
582 EYE HAEMORRHAGE 26 0.0019
583 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 394 0.0019
584 TERMINAL STATE 13 0.0019
585 PAIN IN JAW 55 0.0019
586 HYPOMAGNESAEMIA 27 0.0019
587 BLOOD IRON DECREASED 23 0.0019
588 TRANSIENT ISCHAEMIC ATTACK 65 0.0019
589 TENDERNESS 20 0.0019
590 DEVICE OCCLUSION 27 0.0019
591 PULMONARY HAEMORRHAGE 15 0.0019
592 BLOOD PRESSURE FLUCTUATION 46 0.0019
593 GASTROINTESTINAL PAIN 21 0.0019
594 TOOTH FRACTURE 21 0.0019
595 ADVERSE DRUG REACTION 171 0.0019
596 OEDEMA PERIPHERAL 232 0.0019
597 THIRST 34 0.0019
598 SPINAL DISORDER 18 0.0019
599 BLINDNESS TRANSIENT 14 0.0019
600 BURSITIS 23 0.0019
601 ORTHOSTATIC HYPOTENSION 33 0.0019
602 FATIGUE 1468 0.0019
603 CELLULITIS 95 0.0019
604 THYROID DISORDER 29 0.0019
605 HEART RATE DECREASED 66 0.0019
606 COLON CANCER 28 0.0019
607 LIP DRY 17 0.0019
608 SPEECH DISORDER 98 0.0019
609 SCAR 32 0.0019
610 FEELING ABNORMAL 447 0.0019
611 HERPES ZOSTER 107 0.0019
612 CARPAL TUNNEL SYNDROME 26 0.0019
613 BLOOD COUNT ABNORMAL 28 0.0018
614 TEMPERATURE INTOLERANCE 19 0.0018
615 INTERNAL HAEMORRHAGE 21 0.0018
616 BLOOD POTASSIUM DECREASED 55 0.0018
617 INJECTION SITE RASH 56 0.0018
618 SPINAL OSTEOARTHRITIS 16 0.0018
619 RESPIRATORY DISTRESS 50 0.0018
620 APPETITE DISORDER 12 0.0018
621 INJECTION SITE PAIN 555 0.0018
622 GASTROINTESTINAL DISORDER 162 0.0018
623 INJECTION SITE DISCOMFORT 19 0.0018
624 PARAESTHESIA ORAL 26 0.0018
625 MYOCARDIAL INFARCTION 314 0.0018
626 POOR QUALITY DEVICE USED 18 0.0018
627 OCULAR HYPERAEMIA 85 0.0018
628 BREAST MASS 12 0.0018
629 CARDIAC FAILURE 143 0.0018
630 HOT FLUSH 134 0.0018
631 WEIGHT DECREASED 496 0.0018
632 BLINDNESS UNILATERAL 25 0.0018
633 HYPERSENSITIVITY 329 0.0018
634 TOOTH EXTRACTION 22 0.0018
635 SKIN CANCER 38 0.0018
636 TRICUSPID VALVE INCOMPETENCE 14 0.0018
637 PNEUMONIA ASPIRATION 44 0.0018
638 INCORRECT PRODUCT ADMINISTRATION DURATION 38 0.0018
639 BEDRIDDEN 23 0.0017
640 TOOTH INFECTION 23 0.0017
641 IMMUNODEFICIENCY 26 0.0017
642 BRAIN NEOPLASM 16 0.0017
643 DECREASED APPETITE 403 0.0017
644 WOUND INFECTION 19 0.0017
645 PERICARDIAL EFFUSION 40 0.0017
646 CONJUNCTIVITIS 32 0.0017
647 SOMNOLENCE 346 0.0017
648 DENTAL CARIES 19 0.0017
649 GROIN PAIN 15 0.0017
650 HICCUPS 14 0.0017
651 INSOMNIA 453 0.0017
652 INJECTION SITE SWELLING 130 0.0017
653 BLOOD PRESSURE SYSTOLIC INCREASED 33 0.0017
654 KIDNEY INFECTION 33 0.0017
655 TENDONITIS 26 0.0017
656 MUSCULOSKELETAL STIFFNESS 147 0.0017
657 CORONARY ARTERY OCCLUSION 23 0.0017
658 DYSPEPSIA 165 0.0017
659 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 49 0.0017
660 NICOTINE DEPENDENCE 13 0.0017
661 DEPRESSED MOOD 88 0.0017
662 TRANSAMINASES INCREASED 37 0.0017
663 CHILLS 195 0.0017
664 ECZEMA 87 0.0017
665 FLATULENCE 94 0.0017
666 BLOOD CREATININE INCREASED 108 0.0017
667 OSTEOPENIA 25 0.0016
668 FACIAL PARALYSIS 14 0.0016
669 OFF LABEL USE 1436 0.0016
670 ABDOMINAL PAIN UPPER 337 0.0016
671 BLOOD URINE PRESENT 31 0.0016
672 PRODUCT AVAILABILITY ISSUE 37 0.0016
673 JOINT SWELLING 196 0.0016
674 BLOOD MAGNESIUM DECREASED 14 0.0016
675 JOINT DISLOCATION 17 0.0016
676 ANGINA PECTORIS 46 0.0016
677 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 88 0.0016
678 CLOSTRIDIUM DIFFICILE INFECTION 35 0.0016
679 FLANK PAIN 15 0.0016
680 PHOTOPHOBIA 30 0.0016
681 NEPHROLITHIASIS 73 0.0016
682 FEELING COLD 44 0.0016
683 CEREBROVASCULAR ACCIDENT 266 0.0016
684 INTERSTITIAL LUNG DISEASE 76 0.0016
685 SLUGGISHNESS 16 0.0016
686 THERAPEUTIC RESPONSE DECREASED 95 0.0016
687 NEOPLASM 18 0.0016
688 PRURITUS 601 0.0016
689 ABDOMINAL PAIN 362 0.0016
690 BONE PAIN 91 0.0016
691 ERUCTATION 30 0.0015
692 EATING DISORDER 33 0.0015
693 APHTHOUS ULCER 12 0.0015
694 GLOMERULAR FILTRATION RATE DECREASED 19 0.0015
695 MUSCLE TIGHTNESS 25 0.0015
696 INTESTINAL OBSTRUCTION 58 0.0015
697 ANAPHYLACTIC REACTION 85 0.0015
698 DIARRHOEA 992 0.0015
699 DECREASED IMMUNE RESPONSIVENESS 15 0.0015
700 DEPRESSION 347 0.0015
701 DISCOMFORT 93 0.0015
702 NIGHT SWEATS 49 0.0015
703 BODY TEMPERATURE INCREASED 31 0.0015
704 BALANCE DISORDER 131 0.0015
705 INTERVERTEBRAL DISC DEGENERATION 14 0.0015
706 BLADDER DISORDER 15 0.0015
707 ADVERSE REACTION 20 0.0015
708 OBESITY 24 0.0015
709 ATRIAL FLUTTER 12 0.0015
710 OSTEOARTHRITIS 63 0.0015
711 LEUKAEMIA 14 0.0015
712 ADRENAL INSUFFICIENCY 18 0.0015
713 ROAD TRAFFIC ACCIDENT 62 0.0015
714 SKIN DISCOLOURATION 68 0.0015
715 EYE SWELLING 55 0.0015
716 INJECTION SITE PRURITUS 99 0.0015
717 MYALGIA 251 0.0015
718 ACCIDENTAL OVERDOSE 54 0.0015
719 THERAPY PARTIAL RESPONDER 23 0.0015
720 INJECTION SITE BRUISING 117 0.0015
721 OESOPHAGITIS 16 0.0015
722 HYPOTENSION 293 0.0015
723 RENAL DISORDER 68 0.0015
724 SWELLING FACE 95 0.0015
725 ARRHYTHMIA 69 0.0015
726 DYSPHAGIA 138 0.0015
727 CONTRAINDICATED PRODUCT ADMINISTERED 44 0.0015
728 ABDOMINAL DISCOMFORT 243 0.0014
729 JOINT STIFFNESS 38 0.0014
730 WEIGHT INCREASED 324 0.0014
731 MIGRAINE 138 0.0014
732 VITAMIN D DEFICIENCY 14 0.0014
733 NAUSEA 1136 0.0014
734 TRANSFUSION 15 0.0014
735 MUSCULAR WEAKNESS 161 0.0014
736 BLOOD POTASSIUM INCREASED 23 0.0014
737 DEAFNESS 37 0.0014
738 ASPARTATE AMINOTRANSFERASE INCREASED 75 0.0014
739 BREAST PAIN 15 0.0014
740 SCAB 16 0.0014
741 URTICARIA 235 0.0014
742 CYANOSIS 22 0.0014
743 PRESYNCOPE 34 0.0014
744 DRY SKIN 186 0.0014
745 DIARRHOEA HAEMORRHAGIC 13 0.0014
746 LETHARGY 80 0.0014
747 LIMB DISCOMFORT 43 0.0014
748 FULL BLOOD COUNT DECREASED 28 0.0014
749 DIPLOPIA 36 0.0014
750 DEVICE MECHANICAL ISSUE 19 0.0014
751 PERIPHERAL COLDNESS 19 0.0014
752 HAEMATEMESIS 35 0.0014
753 MOUTH ULCERATION 29 0.0014
754 LOSS OF CONSCIOUSNESS 176 0.0014
755 GENERALISED OEDEMA 17 0.0014
756 VOMITING 645 0.0014
757 RASH 593 0.0014
758 SUPRAVENTRICULAR TACHYCARDIA 13 0.0014
759 MOBILITY DECREASED 97 0.0013
760 DERMATITIS ATOPIC 71 0.0013
761 VERTIGO 82 0.0013
762 COLITIS 51 0.0013
763 PAIN 822 0.0013
764 MENTAL DISORDER 58 0.0013
765 INJECTION SITE ERYTHEMA 165 0.0013
766 PULMONARY ARTERIAL HYPERTENSION 19 0.0013
767 OEDEMA 71 0.0013
768 COMPLICATION ASSOCIATED WITH DEVICE 19 0.0013
769 AMNESIA 85 0.0013
770 IRRITABLE BOWEL SYNDROME 28 0.0013
771 WHITE BLOOD CELL COUNT INCREASED 50 0.0013
772 CARDIOMEGALY 16 0.0013
773 MEMORY IMPAIRMENT 178 0.0013
774 HYPOPHAGIA 33 0.0013
775 DEHYDRATION 172 0.0013
776 INFLUENZA LIKE ILLNESS 106 0.0013
777 DEVICE MALFUNCTION 90 0.0013
778 BLINDNESS 52 0.0013
779 STAPHYLOCOCCAL INFECTION 42 0.0013
780 TINNITUS 58 0.0013
781 TACHYCARDIA 112 0.0013
782 CARDIOVASCULAR DISORDER 32 0.0013
783 SKIN DISORDER 42 0.0013
784 NERVE INJURY 14 0.0013
785 ANAEMIA 240 0.0013
786 BLOOD CALCIUM DECREASED 14 0.0012
787 ACUTE KIDNEY INJURY 190 0.0012
788 LIVER DISORDER 55 0.0012
789 SKIN LESION 34 0.0012
790 REBOUND EFFECT 14 0.0012
791 PYREXIA 428 0.0012
792 NEEDLE ISSUE 36 0.0012
793 AUTOIMMUNE DISORDER 12 0.0012
794 BURNING SENSATION 86 0.0012
795 RENAL PAIN 13 0.0012
796 CLOSTRIDIUM DIFFICILE COLITIS 13 0.0012
797 GASTRITIS 32 0.0012
798 DEVICE DEFECTIVE 21 0.0012
799 HEREDITARY ANGIOEDEMA 13 0.0012
800 CYST 15 0.0012
801 NO ADVERSE EVENT 218 0.0012
802 BRAIN INJURY 12 0.0012
803 BLISTER 67 0.0012
804 JOINT RANGE OF MOTION DECREASED 16 0.0012
805 BLOOD GLUCOSE FLUCTUATION 13 0.0012
806 MOVEMENT DISORDER 38 0.0012
807 BACTERAEMIA 14 0.0012
808 CHOLECYSTITIS 14 0.0012
809 FEELING HOT 72 0.0012
810 RASH ERYTHEMATOUS 56 0.0012
811 GASTROENTERITIS 17 0.0012
812 DYSSTASIA 34 0.0012
813 PROSTATIC SPECIFIC ANTIGEN INCREASED 16 0.0012
814 APHASIA 35 0.0012
815 CHOLELITHIASIS 38 0.0012
816 INTERVERTEBRAL DISC PROTRUSION 25 0.0011
817 INJECTION SITE URTICARIA 28 0.0011
818 HYPOAESTHESIA 170 0.0011
819 BLOOD UREA INCREASED 19 0.0011
820 UPPER GASTROINTESTINAL HAEMORRHAGE 19 0.0011
821 DEVICE ISSUE 101 0.0011
822 TOOTH DISORDER 25 0.0011
823 GALLBLADDER DISORDER 20 0.0011
824 CHROMATURIA 25 0.0011
825 FAECES DISCOLOURED 24 0.0011
826 HYPERTHYROIDISM 16 0.0011
827 TACHYPNOEA 15 0.0011
828 LYMPHADENOPATHY 39 0.0011
829 HEPATIC CYTOLYSIS 14 0.0011
830 ARTHROPATHY 61 0.0011
831 CONFUSIONAL STATE 177 0.0011
832 HALLUCINATION 82 0.0011
833 PROCEDURAL PAIN 30 0.0011
834 DISEASE RECURRENCE 51 0.0011
835 SYSTEMIC LUPUS ERYTHEMATOSUS 38 0.0011
836 UNEVALUABLE EVENT 81 0.0011
837 FIBROMYALGIA 26 0.0011
838 NEUROPATHY PERIPHERAL 101 0.0011
839 BRADYCARDIA 56 0.0011
840 MUSCULOSKELETAL DISORDER 20 0.0010
841 SYNCOPE 105 0.0010
842 FREQUENT BOWEL MOVEMENTS 28 0.0010
843 DELUSION 16 0.0010
844 PSYCHOMOTOR HYPERACTIVITY 17 0.0010
845 INJECTION SITE WARMTH 21 0.0010
846 HYPERHIDROSIS 131 0.0010
847 INFLAMMATION 52 0.0010
848 ABSCESS 16 0.0010
849 WOUND 28 0.0010
850 GLYCOSYLATED HAEMOGLOBIN INCREASED 25 0.0010
851 ERYTHEMA 201 0.0010
852 INJECTION SITE MASS 36 0.0010
853 LYMPHOMA 15 0.0010
854 HEPATIC STEATOSIS 18 0.0010
855 GINGIVAL BLEEDING 13 0.0010
856 BLOOD GLUCOSE INCREASED 179 0.0009
857 BLOOD GLUCOSE DECREASED 45 0.0009
858 SKIN ULCER 24 0.0009
859 DIALYSIS 13 0.0009
860 FLUSHING 93 0.0009
861 MULTIPLE FRACTURES 15 0.0009
862 HYPERKALAEMIA 32 0.0009
863 THINKING ABNORMAL 17 0.0009
864 MELAENA 20 0.0009
865 ABNORMAL DREAMS 25 0.0009
866 PARAESTHESIA 142 0.0009
867 ALOPECIA 177 0.0009
868 FRACTURE 17 0.0009
869 BASAL CELL CARCINOMA 14 0.0009
870 RASH PAPULAR 20 0.0009
871 INCREASED APPETITE 17 0.0009
872 SEIZURE 102 0.0009
873 LABORATORY TEST ABNORMAL 26 0.0009
874 INJECTION SITE REACTION 60 0.0009
875 DISTURBANCE IN ATTENTION 47 0.0009
876 INFUSION RELATED REACTION 57 0.0009
877 BREAST CANCER 80 0.0009
878 FEAR 23 0.0009
879 ANAPHYLACTIC SHOCK 22 0.0009
880 HAEMATOCHEZIA 47 0.0009
881 SEPTIC SHOCK 37 0.0008
882 RED BLOOD CELL COUNT DECREASED 24 0.0008
883 PSORIATIC ARTHROPATHY 34 0.0008
884 RESPIRATORY ARREST 23 0.0008
885 DIABETIC KETOACIDOSIS 20 0.0008
886 LEUKOCYTOSIS 15 0.0008
887 OSTEOMYELITIS 15 0.0008
888 HAEMORRHOIDS 16 0.0008
889 PAIN OF SKIN 22 0.0008
890 HAEMATOMA 21 0.0008
891 DEVICE LEAKAGE 35 0.0008
892 CARDIAC ARREST 66 0.0008
893 COLD SWEAT 14 0.0008
894 CEREBRAL HAEMORRHAGE 28 0.0008
895 FEMUR FRACTURE 24 0.0008
896 TYPE 2 DIABETES MELLITUS 26 0.0008
897 BLOOD GLUCOSE ABNORMAL 14 0.0008
898 HALLUCINATION, VISUAL 16 0.0008
899 INTENTIONAL PRODUCT USE ISSUE 66 0.0008
900 RENAL FAILURE 100 0.0008
901 NIGHTMARE 26 0.0008
902 PRODUCT PHYSICAL ISSUE 15 0.0007
903 DRUG EFFECT INCOMPLETE 27 0.0007
904 RESTLESSNESS 27 0.0007
905 UNRESPONSIVE TO STIMULI 19 0.0007
906 RHEUMATOID ARTHRITIS 83 0.0007
907 IMPAIRED HEALING 24 0.0007
908 HAEMATURIA 25 0.0007
909 ACUTE MYOCARDIAL INFARCTION 21 0.0007
910 PANCREATITIS ACUTE 16 0.0007
911 LACTIC ACIDOSIS 23 0.0007
912 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 13 0.0007
913 NERVOUS SYSTEM DISORDER 22 0.0007
914 ANHEDONIA 18 0.0007
915 HAEMOGLOBIN DECREASED 70 0.0007
916 HEPATIC CANCER 16 0.0007
917 HYPERGLYCAEMIA 24 0.0007
918 ANGIOEDEMA 29 0.0007
919 DRUG INTERACTION 103 0.0006
920 CHRONIC KIDNEY DISEASE 49 0.0006
921 PANCREATITIS 34 0.0006
922 ABDOMINAL PAIN LOWER 16 0.0006
923 BLADDER CANCER 37 0.0006
924 HYPOKALAEMIA 29 0.0006
925 MOOD ALTERED 17 0.0006
926 ERECTILE DYSFUNCTION 16 0.0006
927 DERMATITIS 13 0.0006
928 RECTAL HAEMORRHAGE 26 0.0006
929 PSORIASIS 79 0.0006
930 PLATELET COUNT DECREASED 64 0.0006
931 GASTROINTESTINAL HAEMORRHAGE 50 0.0006
932 DYSKINESIA 24 0.0006
933 PROSTATE CANCER 47 0.0006
934 GASTRIC DISORDER 20 0.0006
935 ADVERSE EVENT 53 0.0006
936 AGITATION 42 0.0006
937 HAEMORRHAGE 59 0.0006
938 PRODUCT SUBSTITUTION ISSUE 32 0.0006
939 DISORIENTATION 22 0.0006
940 PANCREATIC CARCINOMA 16 0.0006
941 IRRITABILITY 33 0.0005
942 RENAL IMPAIRMENT 46 0.0005
943 HEPATIC ENZYME INCREASED 37 0.0005
944 COGNITIVE DISORDER 25 0.0005
945 SUICIDAL IDEATION 49 0.0005
946 MUSCULOSKELETAL PAIN 28 0.0005
947 ANGER 18 0.0005
948 PRODUCT QUALITY ISSUE 72 0.0005
949 DEVICE DISLOCATION 23 0.0005
950 EMOTIONAL DISTRESS 64 0.0005
951 INJECTION SITE HAEMORRHAGE 42 0.0005
952 WHITE BLOOD CELL COUNT DECREASED 57 0.0005
953 DEEP VEIN THROMBOSIS 34 0.0005
954 COLITIS ULCERATIVE 23 0.0005
955 DYSARTHRIA 19 0.0005
956 DISEASE PROGRESSION 58 0.0005
957 PALLOR 13 0.0005
958 SKIN BURNING SENSATION 34 0.0005
959 INJURY 33 0.0005
960 COMA 22 0.0005
961 BREAST CANCER FEMALE 12 0.0004
962 ELECTROCARDIOGRAM QT PROLONGED 16 0.0004
963 INTENTIONAL OVERDOSE 28 0.0004
964 PLASMA CELL MYELOMA 17 0.0004
965 DELIRIUM 15 0.0004
966 NEUTROPENIA 58 0.0004
967 DEVICE BREAKAGE 17 0.0004
968 CRYING 15 0.0004
969 DEVICE DIFFICULT TO USE 27 0.0004
970 RHABDOMYOLYSIS 17 0.0004
971 ALANINE AMINOTRANSFERASE INCREASED 25 0.0004
972 CARDIO-RESPIRATORY ARREST 17 0.0004
973 VISUAL ACUITY REDUCED 13 0.0004
974 HYPOGLYCAEMIA 18 0.0004
975 FEBRILE NEUTROPENIA 24 0.0004
976 MEDICATION ERROR 20 0.0004
977 C-REACTIVE PROTEIN INCREASED 13 0.0004
978 ABNORMAL BEHAVIOUR 14 0.0004
979 MALIGNANT NEOPLASM PROGRESSION 35 0.0003
980 THROMBOCYTOPENIA 38 0.0003
981 EXPOSURE DURING PREGNANCY 21 0.0003
982 SKIN IRRITATION 14 0.0003
983 PANCYTOPENIA 17 0.0003
984 RENAL CANCER 14 0.0003
985 TREATMENT FAILURE 23 0.0003
986 ACNE 21 0.0003
987 AGGRESSION 13 0.0003
988 SUICIDE ATTEMPT 14 0.0002
989 DRUG DOSE OMISSION 23 0.0001
990 TOXICITY TO VARIOUS AGENTS 14 0.0001